Real-World Analysis of the Efficacy and Safety of a Novel Irreversible HER2 Tyrosine Kinase Inhibitor Pyrotinib in Patients with HER2-Positive Metastatic Breast Cancer

Sun Y, Chen B, Li J, Peng L, Li S, Yu X, Li L

Cancer Management and Research 2021, 13:7165-7174

Published Date: 14 September 2021